You are here: Home > Research & Development > Product Pipeline

  Product Pipeline and Commercial Products

 
 R&D Home
  
 
Technology
 
 Products
 
 Partners & Licensing
 
 Patents


 

 

    Commercial Products

 

Commercial Product

Branded Products
(a)

Therapeutic Category

Commercial Status

Partner

Hydromorphone Hydrochloride
8 mg tablets

Dilaudid®
8 mg

Pain

Launched

Owned by Elite,

distributed by Precision Dose, Inc. / TAGI

Lodrane D®

N/A

OTC Allergy

Launched

ECR Pharmaceuticals

Naltrexone Hydrochloride

50 mg

ReVia®

Opioid Antagonist

Launched

Owned by Elite, distributed by Precision Dose, Inc./ TAGI

Phentermine HCl

37.5 mg tablets

Adipex-P® 37.5 mg

Bariatric

Launched

Owned by Elite, distributed by Precision Dose, Inc./ TAGI

Phentermine HCI
15 mg capsules

Adipex-P®

Bariatric Launched Owned by Elite, distributed by Precision Dose, Inc./ TAGI

Phentermine HCI

30 mg capsules

Adipex-P®

Bariatric

Launched

Owned by Elite, distributed by Precision Dose, Inc./ TAGI

Phendimetrazine Tartrate Tablets USP,
35 mg.

Bontril PDM

Bariatric

Launched

Owned by Elite, distributed by Elite and Epic Pharma, LLC

Isradipine
2.5 mg and 5.0 mg capsules

N/A Cardiovascular Pending site transfer Owned and manufactured by Elite, distribution by Epic Pharma, LLC

Dantrolene Sodium
25 mg, 50 mg and 100 mg capsules

Dantrium® Skeletal Muscle Relaxant Pending site transfer Owned by Elite, manufacturing and
 distribution by Epic Pharma, LLC

Loxapine
5mg, 10mg, 25 mg, 50 mg capsules

N/A Antipsychotic Pending site transfer Owned by Elite, manufacturing and
 distribution by Epic Pharma, LLC

Hydroxyzine HCI
10 mg, 25 mg, 50 mg tablets

Atarax, Vistaril Antihistamine Pending site transfer Owned by Elite, manufacturing and
 distribution by Epic Pharma, LLC
Eight Approved ANDA's Undisclosed Undisclosed Pending site transfer Owned by Elite, manufacturing and
 distribution by Epic Pharma, LLC

  

   Contract Manufacturing

  

Commercial Product

Branded Products
(a)

Therapeutic Category

Commercial Status

Partner

Methadone Hydrochloride

10 mg tablets

Dolophine® 
10 mg tablets

Pain

Launched

ThePharmaNetwork

   

   Product Pipeline

       

Programs Under Development

Branded Products
(a)

Therapeutic Category

NDA / ANDA

Development Stage
 

Partner

Extended Release Opioids

N/A

Pain

ANDA / NDA

Scale up

Owned by Elite

ELI-201 OxyContin Pain NDA Pilot Bioequivalence Completed Owned by Elite
ELI-200 Undisclosed Pain NDA Pivotal Bioequivalence Completed Owned by Elite
Abuse Resistant Opioids (b)

N/A

Pain

ANDA / NDA

Scale up

Owned by Elite

Undisclosed Generic

Undisclosed

Undisclosed

ANDA

Pending FDA Approval

Owned by Elite

Undisclosed Generic Undisclosed Undisclosed ANDA Pending FDA Approval Owned by Elite

Undisclosed Intermediate Product

Undisclosed

Undisclosed

ANDA

Scale up

Hi-Tech Pharmacal

Undisclosed

N/A

Undisclosed

NDA

Development

Undisclosed

Undisclosed

Undisclosed

Undisclosed

NDA

Development

Mikah Pharma LLC

Brompheniramine

Maleate with

Pseudoephedrine HCl

24 hour product

NA

Allergy

NDA

Scale-up

Owned by Elite

(a)    The name of our competitor’s branded product if our product is a generic product. 

(b)    Click here to view slide on How Elite's Abuse Resistant Technology Works

 

Elite Pharmaceuticals, Inc. 165 Ludlow Ave., Northvale, NJ 07647    Phone:  201-750-2646  Fax:  201-750-2755 
E Mail:  webmaster@elitepharma.com